Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/112251
Genome editing in human pluripotent stem cells: a systematic approach unrevealing pancreas development and disease
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Although mouse models have represented a major tool for understanding and predicting molecular mechanisms responsible for several human genetic diseases, still species-specific differences between mouse and humans in their biochemical and physiological characteristics represent a major hurdle when translating promising findings into the human setting (1). For instance, in several types of maturity onset diabetes of the young (MODY; autosomal dominant), mice with heterozygous mutations do not develop diabetes (2). In this regard, the derivation of human embryonic stem cells (hESCs) in 1998 represented an unprecedented opportunity for human disease modelling, and a promising source for cell replacement therapies (3). Later on, the possibility to generate patient-derived induced pluripotent stem cells (iPSCs) has opened new venues for the potential translation of stem-cell related studies into the clinic (4).
Matèries (anglès)
Citació
Citació
GARRETA, Elena, MARCO, Andrés, IZPISÚA BELMONTE, Juan carlos, MONTSERRAT, Núria. Genome editing in human pluripotent stem cells: a systematic approach unrevealing pancreas development and disease. _Stem Cell Investigation 2016_. vol. 4. Vol. 11, núm. 1-4. [consulta: 26 de febrer de 2026]. [Disponible a: https://hdl.handle.net/2445/112251]